On October 28, 2022, Impactive Capital LP announced that as of October 24, 2022, it has ceased to beneficially own more than 5% of the outstanding shares of Meridian Bioscience, Inc. Hence, the campaign is deemed to be withdrawn.
Meridian Bioscience, Inc.
Equities
VIVO
US5895841014
Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | |
---|---|---|
-3.18% | 185B | |
-2.68% | 105B | |
-2.23% | 68.9B | |
-6.46% | 46.16B | |
+5.45% | 40.75B | |
+20.09% | 31.11B | |
+11.36% | 24.26B | |
-6.67% | 23.94B | |
-12.70% | 21.86B |